Showing results (11-20 of 481) with videos related to
Sort By:
Pageof 49
Expert Review of Cardiovascular Therapy|December 27, 2005
Clopidogrel use in coronary artery diseaseAaron L Baggish, Marc S SabatineHematology. American Society of Hematology. Education Program|February 20, 2015
Pharmacogenomics of antiplatelet drugsMarc S Sabatine, Jessica L MegaJournal of the American College of Cardiology|March 20, 2003
The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarctionMarc S Sabatine, Elliott M AntmanExpert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Adding clopidogrel to aspirin improves outcome in ST-elevation myocardial infarction patients receiving fibrinolytic therapySean M Donahoe, Marc S SabatineJournal of the American College of Cardiology|June 20, 2015
Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?Robert P Giugliano, Marc S SabatineExpert Review of Cardiovascular Therapy|October 24, 2013
Ticagrelor for acute coronary syndromesSameer Bansilal, Marc P Bonaca, Marc S SabatineCirculation|June 20, 2020
The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-AnalysisMichelle L O'Donoghue, Sabina A Murphy, Marc S SabatinePostgraduate Medicine|July 17, 2016
Focus on PCSK9 Inhibitors: From Genetics to Clinical PracticeMarc S Sabatine, James A Underberg, Michael Koren, et al.American Heart Journal|April 23, 2005
Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trialMarc S Sabatine, Carolyn H McCabe, C Michael Gibson, et al.Circulation|February 25, 2009
Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarctionSusan Cheng, David A Morrow, Sarah Sloan, et al.Pageof 49